Home › Coronary Artery Disease › NCT07691502

Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention

Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention: A Randomized Trial of Routine PCI Versus CCTA-guided PCI

Who can join

Ages 22 and older · All sexes

Inclusion Criteria:

* At least one moderate-severe coronary stenosis on CCTA with an FFRCT ≤0.80 involving no more than two vessels (i.e. target lesion(s) must be FFRCT eligible)
* Referral for non-emergent PCI of at least one de novo stenosis in a native coronary artery with a reference diameter ≥2 mm on CCTA.

Exclusion Criteria:

* Multivessel CAD involving ≥3 vessels.
* Severe left main disease \>50%
* Prior CABG
* Prior PCI in target vessel
* Planned CABG
* Chronic coronary total occlusion in the target vessel
* ST-elevation myocardial infarction
* Emergent PCI
* Cardiac arrest
* Cardiogenic shock
* Scenarios where FFRCT is not possible: inadequate CCTA quality for FFRCT, small vessels \<2 mm, with stents at the target vessel.
* Unstable high-risk NSTE-ACS (hemodynamic instability, refractory angina, unstable arrhythmias, persistent ischemia).
* Patients who are pregnant or nursing or plan to be pregnant in the period up to 2 years following the index procedure will not be approached due to exposure to fluoroscopy.

About the study

The CT-PLAN PCI trial will evaluate whether CCTA-guided PCI improves procedural efficiency compared with routine PCI (without pre-procedural CCTA-guidance for PCI planning) using procedural time as the primary endpoint. Key secondary outcomes will include contrast volume, radiation dose, fluoroscopy time, resource utilization, and periprocedural outcomes including post-PCI physiology, and peri-procedural myocardial injury measured by high-sensitivity cardiac troponin assays.

What is being tested

• CT-guided PCI (procedure)
• Routine PCI (procedure)

Sponsor: Minneapolis Heart Institute Foundation · Participants: 200 · Started: Aug 31, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07691502

Locations in the U.S.

Conditions

• Coronary Artery Disease

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.